Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs

This publication has 16 references indexed in Scilit:

• Induction and Enhancement of Immune Responses to Herpes Simplex Virus Type 2 in Humans by Use of a Recombinant Glycoprotein D Vaccine
  The Journal of Infectious Diseases, 1993
• Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development
  Antiviral Research, 1993
• Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs
  Vaccine, 1992
• Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections
  Antimicrobial Agents and Chemotherapy, 1989
• Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: Factors influencing efficacy
  Antiviral Research, 1989
• Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
  Antiviral Research, 1988
• Herpes simplex virus glycoprotein treatment of recurrent genital herpes reduces cervicovaginal virus shedding in guinea pigs
  Antiviral Research, 1988
• Efficacy of Recombinant Glycoprotein D Subunit Vaccines on the Development of Primary, Recurrent, and Latent Genital Infections with Herpes Simplex Virus Type 2 in Guinea Pigs
  The Journal of Infectious Diseases, 1988
• Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital Herpes
  The Journal of Infectious Diseases, 1988
• Antibody Response, Recurrence Patterns and Subsequent Herpes Simplex Virus Type 2 (HSV-2) Re-infection Following Initial HSV-2 Infection of Guinea-pigs: Effects of Acyclovir
  Journal of General Virology, 1986